Drilling Down Into the Books for Edwards Lifesciences Corporation (EW)

Edwards Lifesciences Corporation (NYSE:EW) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trading with a market value of 31.12B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Edwards Lifesciences Corporation (NYSE:EW) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For EW, the company currently has 1.23 billion of cash on the books, which is offset by 598.6 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 5.83 billion in total assets, balanced by 2.58 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Edwards Lifesciences Corporation (EW) saw 108.1 million in free cash flow last quarter, representing a quarterly net change in cash of 408.7 million. Perhaps most importantly where cash movements are concerned, the company saw about 151.3 million in net operating cash flow.

Edwards Lifesciences Corporation (NYSE:EW) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 894.8 million in total revenues. That represents a quarterly year/year change in revenues of 0.01 in sequential terms, the EW saw sales decline by 0.01.

But what about the bottom line? After all, that’s what really matters in the end. Edwards Lifesciences Corporation (EW) is intriguing when broken down to its core data. The cost of selling goods last quarter was 232.1 million, yielding a gross basic income of 662.7 million. For shareholders, given the total diluted outstanding shares of 215.1 million, this means overall earnings per share of 0.96. Note, this compares with a consensus analyst forecast of 1.08 in earnings per share for its next fiscal quarterly report.

Is Edwards Lifesciences Corporation (NYSE:EW) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 5.16 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 27.52. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Edwards Lifesciences Corporation.

Previous ArticleNext Article

Related Post

Understanding Technical Signals From Gevo, Inc. (G... Gevo, Inc. (NASDAQ:GEVO) gained 33.88% in yesterday’s day, going up from its prior closing price of $0.61 to $0.81, and has now recorded rally in 5 co...
Ford Motor Company (F): How Do the Books Stack Up? Ford Motor Company (NYSE:F) has recently been identified as an interesting stock but more in-depth monitoring is needed for a trade decision. Now trad...
TherapeuticsMD, Inc. (TXMD): Checking the Operatio... TherapeuticsMD, Inc. (NASDAQ:TXMD) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 989...
HollyFrontier Corporation (HFC): Checking the Oper... It's worth it to have a look at HollyFrontier Corporation (NYSE:HFC) as there may be a chasm between the bulls and the bears as far as recent trading ...
Fundamentals in Focus for Fifth Third Bancorp (FIT... Fifth Third Bancorp (NASDAQ:FITB) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 21.8...